Sonic Healthcare Limited
(ASX:SHL) says its interim net profit for the first six months of the financial year was up 1.9 per cent at $174 million.
CEO Dr Colin Goldschmidt says it’s a strong result in the face of challenging market conditions with the pathology company’s German and UK business offsetting weaker results in the US and Australia.
Sonic is continuing on the expansion path recently announcing a contract win to provide laboratory services in Alberta, Canada.
Sonic says it’s on track to achieve full year guidance of 2-4 per cent earnings growth and raised the interim dividend by 7 per cent.
